2,680
Views
0
CrossRef citations to date
0
Altmetric
Drug Evaluation

Romosozumab for the treatment of postmenopausal women at high risk of fracture

, , ORCID Icon &
Pages 11-19 | Received 18 Aug 2022, Accepted 23 Nov 2022, Published online: 05 Dec 2022